You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤

Sibel Arnes

Associate, Principal Investments at Novo Holding A/S
Overview
Relationships
In The News
Paths
Career History

Sibel Arnes

Associate, Principal Investments at Novo Holding A/S

Overview

Number of Relationships
This person is connected to 79 people.

Relationships See Details


Senior Director Principal Investments at Novo Holding A/S

Senior Director Principal Investments at Novo Holding A/S

Managing Director, Principal Investments at Novo Holding A/S

President & Chief Executive Officer at Novo Holding A/S

Director, Principal Investments at Novo Holding A/S

Senior Associate, Principal Investments at Novo Holding A/S

Senior Associate, Principal Investments at Novo Holding A/S

Associate at Novo Principal Investments

Associate at Essex Woodlands Health Ventures UK Ltd.

Former Chief Financial Officer at Novo Holding A/S
See 69 more listings with RelSci Professional.

In The News See More

RelSci
July 22, 2017

Paths to Sibel Arnes

Sibel Arnes
You
Connections via Relationship Science
Sibel Arnes
Sync your contacts to see how you can connect with Sibel Arnes.

Career History

Associate, Principal Investments
Current
Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation’s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark.
Associate
2016 - Current
Novo Large Investments is an active, long-term manager which invests in successful later-stage private and publicly listed life science companies (with a bias towards late-clinical and early commercial stage product-focused companies). Their geographic focus is on companies in Denmark, Europe and North America.The firm acts as venture catalysts, investing later in the life cycle of promising life science companies, aiming to catalyze their value by providing ongoing support in the form of constructive advice and access to their network, insight and capabilities until tangible results materialize.Novo Large Investments typically invests USD 20-50 million in companies based on unique science which promote compelling, commercially relevant products and which are driven by insightful leadership, and have the ability to go substantially higher when required. They prefer to take significant minority stakes in their investee companies.

Other Affiliations

Sibel Arnes is affiliated with Novo Holding A/S, Novo Principal Investments.

You've reached your 7 free profiles limit this month.

Upgrade to RelSci Pro today to enjoy unlimited profile views and much more!

Start My Free Trial
Still not convinced? Check out our full listing of features here.